Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Nov 07 2023

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/press-release-nov-07-2023-15

Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6Read the transcript of Glenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 07, 2023, titled "Glenmark Pharmaceuticals receives ANDA approval forFluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10mg".

Glenmark Pharmaceuticals Limited on 6ix

In the deck

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases